ScholarIQanswers from OpenAlex
Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
PaperCitations, authors & open-access status
Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease have?
ScholarIQcitation count
Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease has 1,834 citations in the OpenAlex counts ScholarIQ stores.
When was Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease published?
ScholarIQyear
Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease has 2016 year in the ScholarIQ index.
What is the open-access status of Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease?
ScholarIQoa status
Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease has bronze oa status in the ScholarIQ index.
What is the DOI of Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease?
ScholarIQdoi
The DOI for Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease is on the source record.
What is the OpenAlex record for Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease?
ScholarIQopenalex
The OpenAlex for Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease is on the source record.